Close search filters
Changing filters will change the listed Success Criteria and Techniques
Category
Topic
Search results (341)
Video
What are biosimilars?
October 17, 2022
To help clients prepare for the wave of biosimilars on the horizon, we answer some basic questions about these potentially game-changing medications.
Video
Strategies to Encourage the Adoption of Biosimilars
November 04, 2022
Here are three ways plan sponsors can promote and manage the appropriate use of biosimilars to improve drug affordability and access for members.
Newsroom
Express Scripts Announces Strategic Partnership with Centene to Unlock Greater Prescription Drug Savings
October 25, 2022
Article
High Specialty Drug Costs: A Challenge in Need of Powerful Protection
November 02, 2022
Plan sponsors are overlooking simple strategies to increase specialty medication adherence.
Newsroom
Evernorth Enters Strategic Collaboration with VillageMD to Accelerate Value-Based Services and Care Delivery Strategy
November 07, 2022
Newsroom
MDLIVE Announces Evolution of Virtual Primary Care To Improve Health Outcomes for Patients with Chronic Conditions
November 14, 2022
New program uses remote vital monitoring and real-time reporting to give doctors unparalleled insights into their patients’ health between appointments – forging lasting relationships between doctors ...
Article
Combining behavioral health with cancer treatment can improve patient outcomes
Being diagnosed and living with cancer can cause significant psychological stress.
Read MoreArticle
Evernorth employees provide outstanding health care services to customers and patients
June 05, 2023
Get to know the Evernorth employees who are working hard to provide excellent health care services to members.
Article
The Pharmacy Benefit Management Team: Helping Patients Access Affordable Prescription Drugs Safely and Efficiently
November 28, 2022
Pharmacy benefit managers (PBMs) like Express Scripts are uniquely positioned to help patients in numerous ways.
Article
Express Scripts To Begin Adding Inflammatory Conditions Biosimilars to Largest Formularies Next Year
December 05, 2022